Genor Biopharma Holdings Limited (HKG:6998)
Hong Kong · Delayed Price · Currency is HKD 2.730
+0.060 (2.25%)
Jul 18, 2025, 4:08 PM HKT
Genor Biopharma Holdings Market Cap
Genor Biopharma Holdings has a market cap or net worth of 1.42 billion as of July 18, 2025. Its market cap has increased by 119.78% in one year.
Market Cap
1.42B
Enterprise Value
298.74M
Revenue
219.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.73
Market Cap Chart
Since October 7, 2020, Genor Biopharma Holdings's market cap has decreased from 13.45B to 1.42B, a decrease of -89.41%. That is a compound annual growth rate of -37.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 1.42B | 59.38% |
| Dec 31, 2024 | 893.67M | 49.08% |
| Dec 29, 2023 | 599.44M | -54.84% |
| Dec 30, 2022 | 1.33B | -62.64% |
| Dec 31, 2021 | 3.55B | -63.82% |
| Dec 31, 2020 | 9.82B | -26.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 259.57B |
| Hansoh Pharmaceutical Group Company | 205.13B |
| Innovent Biologics | 152.31B |
| JD Health International | 149.93B |
| Akeso | 125.21B |
| Sino Biopharmaceutical | 115.18B |
| WuXi Biologics | 115.16B |
| CSPC Pharmaceutical Group | 102.41B |